Align Technology (ALGN) PT Lowered to $635 at Jefferies as Omicron Temporarily Stalls Aligner Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts ALGN Hot Sheet
Rating Summary:
22 Buy, 10 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 12
Join SI Premium – FREE
Jefferies analyst Brandon Couillard lowered the price target on Align Technology (NASDAQ: ALGN) to $635.00 (from $720.00) after the company reported a 4Q revs/EPS beat on much better scanner demand. However, aligner volumes (-4% Q/Q) were weak, driven by disruption from Omicron in December. This negatively impacted overall Total Revenue by 3%.
The analyst reiterated a Buy rating, stating "That said, the COVID impact is diminishing, as volumes have improved M/M in Jan, giving mgmt confidence to reaffirm its +20-30% growth outlook for '22. Valuation is attractive on recent weakness."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fortune Brands (FBIN) PT Lowered to $58 at DA Davidson
- AMD (AMD) PT Raised to $600 at DA Davidson
- Amgen (AMGN) PT Raised to $530 at UBS
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
